MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 26, 2008; DOI: 10.1124/mol.108.048066


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.048066v1
74/3/685    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by van der Hoeven, D.
Right arrow Articles by Auchampach, J. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Hoeven, D.
Right arrow Articles by Auchampach, J. A.


Received for publication April 21, 2008.
Revised June 25, 2008.
Accepted for publication June 25, 2008.

Activation of the A3 Adenosine Receptor Suppresses Superoxide Production and Chemotaxis of Mouse Bone Marrow Neutrophils

Dharini van der Hoeven 1, Tina C. Wan 1, John A. Auchampach 1*

1 Medical College of Wisconsin

* Address correspondence to: E-mail: jauchamp{at}mcw.edu

Abstract

Adenosine is formed in injured/ischemic tissues where it suppresses the actions of essentially all cells of the immune system. Most of the anti-inflammatory actions of adenosine have been attributed to signaling through the Gs protein-coupled A2A adenosine receptor (AR). Here, we report that the A3AR is highly expressed in murine neutrophils isolated from bone marrow. Selective activation of the A3AR with CP-532,903 potently inhibited mouse bone marrow neutrophil superoxide generation and chemotaxis induced by various activating agents. The selectivity of CP-532,903 was confirmed in assays using neutrophils obtained from A2AAR and A3AR gene "knock-out" mice. In a model of thioglycollate-induced inflammation, treating mice with CP-532,903 inhibited recruitment of leukocytes into the peritoneum by specifically activating the A3AR. Collectively, our findings support the theory that the A3AR contributes to the anti-inflammatory actions of adenosine on neutrophils, and provide a potential mechanistic explanation for the efficacy of A3AR agonists in animal models of inflammation, i.e., inhibition of neutrophil-mediated tissue injury.


Key words: Adenosine, Leukocytes/Mast cells





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics